These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22925325

  • 1. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial.
    Ou CY, Kuo HC, Wang L, Hsu TY, Chuang H, Liu CA, Chang JC, Yu HR, Yang KD.
    Clin Exp Allergy; 2012 Sep; 42(9):1386-96. PubMed ID: 22925325
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.
    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R.
    Pediatrics; 2008 Apr; 121(4):e850-6. PubMed ID: 18332075
    [Abstract] [Full Text] [Related]

  • 3. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
    Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE.
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
    [Abstract] [Full Text] [Related]

  • 4. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort.
    Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E.
    J Allergy Clin Immunol; 2009 Feb; 123(2):335-41. PubMed ID: 19135235
    [Abstract] [Full Text] [Related]

  • 5. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S.
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [Abstract] [Full Text] [Related]

  • 6. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases.
    Kukkonen K, Kuitunen M, Haahtela T, Korpela R, Poussa T, Savilahti E.
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 1):67-73. PubMed ID: 19566584
    [Abstract] [Full Text] [Related]

  • 7. Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates.
    Kopp MV, Goldstein M, Dietschek A, Sofke J, Heinzmann A, Urbanek R.
    Clin Exp Allergy; 2008 Apr; 38(4):602-10. PubMed ID: 18167121
    [Abstract] [Full Text] [Related]

  • 8. Probiotics during weaning reduce the incidence of eczema.
    West CE, Hammarström ML, Hernell O.
    Pediatr Allergy Immunol; 2009 Aug; 20(5):430-7. PubMed ID: 19298231
    [Abstract] [Full Text] [Related]

  • 9. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
    Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E.
    Lancet; 2001 Apr 07; 357(9262):1076-9. PubMed ID: 11297958
    [Abstract] [Full Text] [Related]

  • 10. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis.
    Chen YS, Jan RL, Lin YL, Chen HH, Wang JY.
    Pediatr Pulmonol; 2010 Nov 07; 45(11):1111-20. PubMed ID: 20658483
    [Abstract] [Full Text] [Related]

  • 11. Probiotics in primary prevention of allergic disease--follow-up at 8-9 years of age.
    West CE, Hammarström ML, Hernell O.
    Allergy; 2013 Aug 07; 68(8):1015-20. PubMed ID: 23895631
    [Abstract] [Full Text] [Related]

  • 12. Ovalbumin-specific immunoglobulins A and G levels at age 2 years are associated with the occurrence of atopic disorders.
    Kukkonen AK, Savilahti EM, Haahtela T, Savilahti E, Kuitunen M.
    Clin Exp Allergy; 2011 Oct 07; 41(10):1414-21. PubMed ID: 21771118
    [Abstract] [Full Text] [Related]

  • 13. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study.
    Huurre A, Laitinen K, Rautava S, Korkeamäki M, Isolauri E.
    Clin Exp Allergy; 2008 Aug 07; 38(8):1342-8. PubMed ID: 18477013
    [Abstract] [Full Text] [Related]

  • 14. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant.
    Rautava S, Kainonen E, Salminen S, Isolauri E.
    J Allergy Clin Immunol; 2012 Dec 07; 130(6):1355-60. PubMed ID: 23083673
    [Abstract] [Full Text] [Related]

  • 15. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.
    Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M.
    Allergy; 2005 Apr 07; 60(4):494-500. PubMed ID: 15727582
    [Abstract] [Full Text] [Related]

  • 16. Increased activation of GATA-3, IL-2 and IL-5 of cord blood mononuclear cells in infants with IgE sensitization.
    Marschan E, Honkanen J, Kukkonen K, Kuitunen M, Savilahti E, Vaarala O.
    Pediatr Allergy Immunol; 2008 Mar 07; 19(2):132-9. PubMed ID: 17651376
    [Abstract] [Full Text] [Related]

  • 17. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials.
    Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E.
    Pediatrics; 2013 Sep 07; 132(3):e666-76. PubMed ID: 23958764
    [Abstract] [Full Text] [Related]

  • 18. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.
    Clin Ther; 2011 Jul 07; 33(7):828-40. PubMed ID: 21741092
    [Abstract] [Full Text] [Related]

  • 19. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.
    Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A.
    Clin Exp Allergy; 2012 Jan 07; 42(1):112-22. PubMed ID: 22092692
    [Abstract] [Full Text] [Related]

  • 20. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth.
    Taylor AL, Hale J, Hales BJ, Dunstan JA, Thomas WR, Prescott SL.
    Pediatr Allergy Immunol; 2007 Feb 07; 18(1):10-9. PubMed ID: 17295794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.